Cite
Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.
MLA
Silva Sousa, Eduardo Henrique, et al. “Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.” ACS Chemical Biology, vol. 11, no. 7, July 2016, pp. 2057–65. EBSCOhost, https://doi.org/10.1021/acschembio.6b00222.
APA
Silva Sousa, E. H., Ridnour, L. A., Gouveia, F. S., Jr, Silva da Silva, C. D., Wink, D. A., de França Lopes, L. G., & Sadler, P. J. (2016). Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy. ACS Chemical Biology, 11(7), 2057–2065. https://doi.org/10.1021/acschembio.6b00222
Chicago
Silva Sousa, Eduardo Henrique, Lisa A Ridnour, Florêncio S Gouveia Jr, Carlos Daniel Silva da Silva, David A Wink, Luiz Gonzaga de França Lopes, and Peter J Sadler. 2016. “Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.” ACS Chemical Biology 11 (7): 2057–65. doi:10.1021/acschembio.6b00222.